Results 21 to 30 of about 17,861,189 (258)

A technique for approximating transition rates from published survival analyses

Cost Effectiveness and Resource Allocation, 2019
Background Quality-adjusted-life-years (QALYs) are used to concurrently quantify morbidity and mortality within a single parameter. For this reason, QALYs can facilitate the discussion of risks and benefits during patient counseling regarding treatment ...
Markian A. Pahuta, Joel Werier, Eugene K. Wai, Roy A. Patchell, Doug Coyle   +4 more
doaj   +1 more source

QALY losses for chronic diseases and its social distribution in the general population: results from the Belgian Health Interview Survey

BMC Public Health, 2022
Background The burden of chronic diseases is rapidly rising, both in terms of morbidity and mortality. This burden is disproportionally carried by socially disadvantaged population subgroups.
Lisa Van Wilder, Brecht Devleesschauwer, Els Clays, Johan Van der Heyden, Rana Charafeddine, Aline Scohy, Delphine De Smedt   +6 more
doaj   +1 more source

The Estimate of Parental Quality of Life Loss Due to Respiratory Syncytial Virus (RSV) Hospitalization

Diseases, 2023
Background: Respiratory syncytial virus (RSV) is one of the leading causes of pediatric hospitalizations, mainly in children under 2 years of age. Hospitalization affects the caregivers’ quality of life (QoL).
August Wrotek, Oliwia Wrotek, Teresa Jackowska   +2 more
doaj   +1 more source

Willingness to pay for a quality-adjusted life year: an evaluation of attitudes towards risk and preferences. [PDF]

BMC Health Serv Res, 2014
This paper examines the Willingness to Pay (WTP) for a quality-adjusted life year (QALY) expressed by people who attended the healthcare system as well as the association of attitude towards risk and other personal characteristics with their ...
Martín-Fernández J, Polentinos-Castro E, del Cura-González MI, Ariza-Cardiel G, Abraira V, Gil-LaCruz AI, García-Pérez S.   +6 more
europepmc   +2 more sources

Eliciting a value set for the Swedish capability-adjusted life years instrument (CALY-SWE) [PDF]

, 2023
Purpose: Our aim was to elicit a value set for Capability-Adjusted Life Years Sweden (CALY-SWE); a capability-grounded quality of life instrument intended for use in economic evaluations of social interventions with broad consequences beyond health ...
Norström, Fredrik, Lindholm, Lars, Ssegonja, R, Ssegonja, Richard, Månsdotter, A, Norström, F, Feldman, Inna,, Mulhern, B, Hjelte, Jan, Lindholm, L, Norström, Fredrik,, Meili, Kaspar Walter, Ssegonja, Richard,, Meili, KW, Hjelte, J, Lindholm, Lars,, Månsdotter, Anna, Mulhern, Brendan,, Månsdotter, Anna,, Mulhern, Brendan, Hjelte, Jan,, Feldman, Inna, Meili, Kaspar Walter,, Feldman, I   +23 more
core   +1 more source

A pharmaco-economic evaluation of deferasirox for treating patients with iron overload caused by transfusion-dependent thalassemia in Taiwan

Journal of the Formosan Medical Association, 2013
The newly available iron chelator deferasirox (Exjade, Novartis) is expected to provide better long-term clinical outcomes and improved quality of life for patients with thalassemia than its predecessor, deferoxamine (Desferal, Novartis), because of its ...
Wan-Ling Ho, Kuo-Piao Chung, Szu-Sheng Yang, Meng-Yao Lu, Shiann-Tarng Jou, Hsiu-Hao Chang, Yung-Li Yang, Dong-Tsamn Lin, Kai-Hsin Lin   +8 more
doaj   +1 more source

An exploratory study to estimate cost-effectiveness threshold value for life saving treatments in western Iran

Cost Effectiveness and Resource Allocation, 2020
Background Cost-effectiveness analysis provides a crucial means for evidence-informed decision-making on resource allocation. This study aims to elicit individuals' willingness to pay (WTP) for one additional quality-adjusted life-year (QALY) gained from
Najmeh Moradi, Abraha Woldemichael, Parisa Malekian, Delnia Moradi Rotvandi, Satar Rezaei   +4 more
doaj   +1 more source

Life year (LY) and quality-adjusted life year (QALY) gained by age for fibrosis stages F1-F4 (Fig 1A-1D).

, 2016
Life year (LY) and quality-adjusted life year (QALY) gained by age for fibrosis stages F1-F4 (Fig 1A-1D).
Ehud Melzer (3154719), Yaakov Maor (3154713), Stephen D. H. Malnick (3154722), Moshe Leshno (3154716)   +3 more
core   +1 more source

Base-case results of expected mortality, cost, and quality-adjusted life-year (QALY) loss.

, 2018
Base-case results of expected mortality, cost, and quality-adjusted life-year (QALY) loss.
Nok-hang Leung (5563508), Joyce H. S. You (318736), Margaret Ip (225393), Minghuan Jiang (440640)   +3 more
core   +1 more source

Costs and quality of life in a randomized trial comparing minimally invasive and open distal pancreatectomy (LEOPARD trial) [PDF]

, 2019
Background: Minimally invasive distal pancreatectomy decreases time to functional recovery compared with open distal pancreatectomy, but the cost-effectiveness and impact on disease-specific quality of life have yet to be established.
van Santvoort, H. C., Daams, F., Suker, M., de Rooij, T., Besselink, M. G., Dejong, C. H., van Duyn, E. B., Klaase, J. M., de Kleine, R. H., Patijn, G. A., Kazemier, G., Koerkamp, B. Groot, Festen, S., Luyer, M., van Laarhoven, C. J., van Eijck, C. H., van Dam, R. M., van den Boezem, P. B., Gerhards, M. F., Hilal, M. Abu, Boerma, D., Strating, E. A., de Hingh, I. H., van Hilst, J., de Boer, M. T., Steenvoorde, P., Dijkgraaf, M. G., Abu Hilal, M., Groot Koerkamp, B.   +28 more
core   +2 more sources